[
  {
    "ts": null,
    "headline": "Jim Cramer on Eli Lilly (LLY) – “Own Eli Lilly, Going to a Trillion Dollars!”",
    "summary": "We recently published a list of Jim Cramer’s Take on These 10 Stocks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. On Wednesday, Jim Cramer, the host of Mad Money, shared his concerns about President Donald Trump’s approach […]",
    "url": "https://finnhub.io/api/news?id=531256d09d141ae02490f6e77b23dbef2f2e1848545fdd915fe73a65bb5826a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743803688,
      "headline": "Jim Cramer on Eli Lilly (LLY) – “Own Eli Lilly, Going to a Trillion Dollars!”",
      "id": 133727266,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer’s Take on These 10 Stocks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. On Wednesday, Jim Cramer, the host of Mad Money, shared his concerns about President Donald Trump’s approach […]",
      "url": "https://finnhub.io/api/news?id=531256d09d141ae02490f6e77b23dbef2f2e1848545fdd915fe73a65bb5826a0"
    }
  },
  {
    "ts": null,
    "headline": "Trump admin. to reportedly drop Medicare GLP-1 plan",
    "summary": "The Trump administration has decided not to back a Biden administration plan that would have allowed Medicare to pay for obesity drugs, according to a report from Bloomberg. Shares of both Eli Lilly (LLY) and Novo Nordisk (NVO) traded lower on the news. Learn more in the video above. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.",
    "url": "https://finnhub.io/api/news?id=9c52700a95c70e33f32c2546f3ac01e7412649ed46d28660718d0e8dd3ceeeb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743801437,
      "headline": "Trump admin. to reportedly drop Medicare GLP-1 plan",
      "id": 133727267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The Trump administration has decided not to back a Biden administration plan that would have allowed Medicare to pay for obesity drugs, according to a report from Bloomberg. Shares of both Eli Lilly (LLY) and Novo Nordisk (NVO) traded lower on the news. Learn more in the video above. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.",
      "url": "https://finnhub.io/api/news?id=9c52700a95c70e33f32c2546f3ac01e7412649ed46d28660718d0e8dd3ceeeb2"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs",
    "summary": "Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs",
    "url": "https://finnhub.io/api/news?id=b011dbd14c867eea7b1328f5f34f42f6829e0e57007ac7650534d1633e9d5d1a",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743796808,
      "headline": "Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs",
      "id": 133739131,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs",
      "url": "https://finnhub.io/api/news?id=b011dbd14c867eea7b1328f5f34f42f6829e0e57007ac7650534d1633e9d5d1a"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies",
    "summary": "Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies",
    "url": "https://finnhub.io/api/news?id=5d5ed445c3482d6fed7fd8578939ca92ab711fd29e299f034aad7478a01d1aa9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743790980,
      "headline": "Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies",
      "id": 133739170,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies",
      "url": "https://finnhub.io/api/news?id=5d5ed445c3482d6fed7fd8578939ca92ab711fd29e299f034aad7478a01d1aa9"
    }
  },
  {
    "ts": null,
    "headline": "Edesa Biotech Appoints Weiler as CFO, Succeeding Lemieux",
    "summary": "Edesa Biotech Appoints Weiler as CFO, Succeeding Lemieux",
    "url": "https://finnhub.io/api/news?id=efee9600112a908848fdf21c5ad3eca3f8482e5942f033516b280bb15e6755ed",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784860,
      "headline": "Edesa Biotech Appoints Weiler as CFO, Succeeding Lemieux",
      "id": 133739171,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Edesa Biotech Appoints Weiler as CFO, Succeeding Lemieux",
      "url": "https://finnhub.io/api/news?id=efee9600112a908848fdf21c5ad3eca3f8482e5942f033516b280bb15e6755ed"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
    "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=9a1cc642c0c952b257a50dc1801e4c4b476a39211f41ed5cb1113c17b2270057",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784260,
      "headline": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "id": 133739172,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=9a1cc642c0c952b257a50dc1801e4c4b476a39211f41ed5cb1113c17b2270057"
    }
  },
  {
    "ts": null,
    "headline": "Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal",
    "summary": "Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for investors. Click for my SGMO stock update.",
    "url": "https://finnhub.io/api/news?id=6f98aa3397cc409f6c1bf3034d53536a90ac0b780c700cf099537c7b7d92efa8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743778657,
      "headline": "Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal",
      "id": 133721318,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2200067129/image_2200067129.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for investors. Click for my SGMO stock update.",
      "url": "https://finnhub.io/api/news?id=6f98aa3397cc409f6c1bf3034d53536a90ac0b780c700cf099537c7b7d92efa8"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says You Should ‘Stay Long’ Eli Lilly (LLY) Because of These Reasons",
    "summary": "We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Trump’s Trade Wars. In this article, we are going to take a look at where Eli Lilly (NYSE:LLY) stands against other stocks that Jim Cramer was talking about amid Trump’s trade wars. Jim Cramer in a latest program on CNBC […]",
    "url": "https://finnhub.io/api/news?id=694cbf613140637d3f9465f784904f25178a8d72dfd7ea431dd4675aac2aa0fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743774057,
      "headline": "Jim Cramer Says You Should ‘Stay Long’ Eli Lilly (LLY) Because of These Reasons",
      "id": 133719337,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Trump’s Trade Wars. In this article, we are going to take a look at where Eli Lilly (NYSE:LLY) stands against other stocks that Jim Cramer was talking about amid Trump’s trade wars. Jim Cramer in a latest program on CNBC […]",
      "url": "https://finnhub.io/api/news?id=694cbf613140637d3f9465f784904f25178a8d72dfd7ea431dd4675aac2aa0fe"
    }
  },
  {
    "ts": null,
    "headline": "1 Ideal Buy From 23 \"Safer\" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)",
    "summary": "Discover top investment opportunities: Fortune 50 highlights admired companies with strong dividends. Read the full list of stock picks here on Seeking Alpha.",
    "url": "https://finnhub.io/api/news?id=32d998c2fae31ad28c34ec6e39c3013ff821c16b7608d3c185838636ef8c20c7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743771672,
      "headline": "1 Ideal Buy From 23 \"Safer\" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)",
      "id": 133719190,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172736149/image_172736149.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Discover top investment opportunities: Fortune 50 highlights admired companies with strong dividends. Read the full list of stock picks here on Seeking Alpha.",
      "url": "https://finnhub.io/api/news?id=32d998c2fae31ad28c34ec6e39c3013ff821c16b7608d3c185838636ef8c20c7"
    }
  }
]